Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) was introduced in 1968 and is now the ‘gold standard’ for imaging of the biliary tree. The subsequent development of non-invasive diagnostic procedures such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasonography (EUS), means that ERCP is now largely reserved for therapeutic rather than diagnostic indications.1 Endoscopic retrograde cholangiopancreatography offers a range of possible interventions for patients, including those deemed at too high risk for surgery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.